Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others.1,2
1 AC5-G, AC5-V, and AC5 Surgical Hemostat are currently investigational devices limited by law to investigational use.
2 AC5, AC5-G, AC5-V and associated logos are trademarks and/or registered trademarks of Arch Therapeutics, Inc. and/or its subsidiaries.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 235 Walnut Street, Framingham,ma 01702,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- archtherapeutics.com
- Keywords
- biotechnology, wound care, interventional healthcare, hemostasis, sealants, self-assembling peptide technology, AC5, dermal science, biosurgery, surgery, trauma.
- HQ
- Framingham, MA
Arch Therapeutics, Inc (Otcqb:arth) Questions
Arch Therapeutics, Inc (Otcqb:Arth)'s website is archtherapeutics.com
Arch Therapeutics, Inc (Otcqb:Arth)'s LinkedIn profile is https://www.linkedin.com/company/arch-therapeutics-inc
Arch Therapeutics, Inc (Otcqb:Arth) has
6 employees.
View email and phone details for 6
employees at Arch Therapeutics, Inc (Otcqb:Arth).
Arch Therapeutics, Inc (Otcqb:Arth)'s industry is
Biotechnology Research
Arch Therapeutics, Inc (Otcqb:Arth)'s top competitors are
Nixon Elementary School,
International Journal Of Tissue Repair,
Cersci Therapeutics,
Reddress Medical,
Candela Medical,
Vertex Pharmaceuticals,
Medela,
Tenaxis Medical,
Akoya Biosciences, Inc.,
Movewellcoach.
Arch Therapeutics, Inc (Otcqb:Arth)'s categories are Biotechnology Research
Arch Therapeutics, Inc (Otcqb:Arth)'s founding year is 2006
